Carl Zeiss Meditec will invest in Precise Bio and fund the further development of Precise Bio's two cornea transplant products and has exclusive worldwide commercialization rights for these products ...
Please provide your email address to receive an email when new articles are posted on . Carl Zeiss Meditec and Precise Bio have partnered to develop and commercialize fabricated corneal tissue for ...
Activities include the Carl Zeiss Day and opening of new German Optical Museum in Jena. Highlight of the celebrations will be Carl Zeiss Day in the city of Jena on 11 September. Carl Zeiss, the ...
Ophthalmic and microsurgery device maker Carl Zeiss Meditec AG is investing in regenerative medicine startup Precise Bio Ltd. to jointly develop 4D bio-fabricated corneal transplants for diseases that ...
The FDA approved Carl Zeiss Meditec’s laser for the treatment of myopia, or nearsightedness, in patients aged 22 and older. The VisuMax Femtosecond Laser corrects myopia by removing eye tissue to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback